Spectrum Pharma To Present Corporate Update At The Bank of America Merrill Lynch 2016 Healthcare Conference On May 10th

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the Bank of America Merrill Lynch 2016 Healthcare Conference being held at the Encore at the Wynn in Las Vegas, Nevada. The Company presentation is on Tuesday, May 10, 2016, at 10:40 AM PT.